Case Studies from across the Catapults
- Skills (11),
- Regional growth (18),
- Highlights (27),
- Equality, Diversity and Inclusion (12),
- International (12),
- Academic engagement (19),
- Net Zero (23),
- Health (18),
- Digital technologies (18),
- Business growth (29),
- Supply chains (6),
- Leveraging Investment (19),
Themes (Reset)
- Cross-Catapult (2),
- Cell and Gene Therapy (15),
- Compound Semiconductor Applications (12),
- Connected Places (13),
- Digital (14),
- Energy Systems (14),
- High Value Manufacturing (18),
- Medicines Discovery (16),
- Offshore Renewable Energy (16),
- Satellite Applications (14),
Catapults (Reset)
Medicines Discovery
Case Study
Alchemab Therapeutics secures private funding for new treatments following collaboration
In 2021 Alchemab and Medicines Discovery Catapult (MDC) collaborated on a Huntington’s disease focussed project, which supported Alchemab in securing significant private investment.
Medicines Discovery
Case Study
The Psychiatry Consortium – exploring new treatments for mental health conditions
Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.
Page 1 of 1